Related Experiment Video
Updated: Jun 26, 2026
03:08
Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
Approaches towards expression profiling the response to treatment.
Breast Cancer Research : BCR
|January 16, 2009
Summary
Gene expression studies in breast cancer are shifting focus from pre-treatment tumor characterization to evaluating treatment effects. This approach aims to predict therapy response and improve patient selection, but requires careful experimental design.
Area of Science:
- Oncology
- Genomics
- Biomedical Research
Background:
- Extensive breast cancer gene expression research has historically focused on characterizing tumors before treatment.
- Recent studies increasingly analyze treatment effects on tumors using gene expression profiling.
- The shift is from long-term prognosis prediction to assessing treatment impact and predicting therapeutic response.
Discussion:
- Utilizing post-treatment or paired pre- and post-treatment samples offers insights into treatment mechanisms.
- Gene expression analysis can potentially identify patients who will benefit from specific therapies.
- Careful consideration of experimental design is crucial for the validity of these new approaches.
Key Insights:
- Gene expression profiling is evolving to assess treatment efficacy in breast cancer.
- The focus is moving towards personalized medicine by predicting treatment response.
- Robust experimental design is paramount for reliable results in treatment-focused gene expression studies.
Outlook:
- Future research will likely refine gene expression techniques for personalized breast cancer treatment.
- This approach holds promise for optimizing therapeutic strategies and patient outcomes.
- Addressing experimental design challenges will be key to unlocking the full potential of this research area.
Related Concept Videos
01:33Proteomics
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...